Artificial intelligence (AI)-guided screening for atrial fibrillation (AF) based on ECGs can successfully identify patients who are more likely to have the arrhythmia detected on subsequent monitoring ...
TCTMD reported in-depth on the TAILORED-AF trial, May 29, 2024, at the HRS 2024 meeting. The full manuscript was subsequently published in Nature Medicine on February 14, 2025. The published results ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results